Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Boyle

Showing results (961-970 of 983) with videos related to

Pageof 99
Sort By:
Genome Research|July 14, 2011
Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identityLingyun Song, Zhancheng Zhang, Linda L Grasfeder, et al.
Infection and Immunity|June 24, 2004
Description of the transcriptomes of immune response-activated hemocytes from the mosquito vectors Aedes aegypti and Armigeres subalbatusLyric C Bartholomay, Wen-Long Cho, Thomas A Rocheleau, et al.
Angewandte Chemie (International Ed. in English)|December 17, 2009
Binaphthyl-based dicationic peptoids with therapeutic potentialJohn B Bremner, Paul A Keller, Stephen G Pyne, et al.
Acta Crystallographica. Section D, Biological Crystallography|September 27, 2006
Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracisK Au, N S Berrow, E Blagova, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 24, 2018
CFTR modulator theratyping: Current status, gaps and future directionsJohn Paul Clancy, Calvin U Cotton, Scott H Donaldson, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2008
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitorsAlita A Miller, Gordon L Bundy, John E Mott, et al.
The New England Journal of Medicine|November 19, 2010
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutationFrank J Accurso, Steven M Rowe, J P Clancy, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Multi-platform framework for mapping somatic retrotransposition in human tissuesSeunghyun Wang, Mingyun Bae, Jinhao Wang, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
Nature Communications|January 8, 2016
Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomesHernan Lorenzi, Asis Khan, Michael S Behnke, et al.
Pageof 99

Showing results (961-970 of 983) with videos related to

Sort By:
Pageof 99
Genome Research|July 14, 2011
Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identityLingyun Song, Zhancheng Zhang, Linda L Grasfeder, et al.
Infection and Immunity|June 24, 2004
Description of the transcriptomes of immune response-activated hemocytes from the mosquito vectors Aedes aegypti and Armigeres subalbatusLyric C Bartholomay, Wen-Long Cho, Thomas A Rocheleau, et al.
Angewandte Chemie (International Ed. in English)|December 17, 2009
Binaphthyl-based dicationic peptoids with therapeutic potentialJohn B Bremner, Paul A Keller, Stephen G Pyne, et al.
Acta Crystallographica. Section D, Biological Crystallography|September 27, 2006
Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracisK Au, N S Berrow, E Blagova, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 24, 2018
CFTR modulator theratyping: Current status, gaps and future directionsJohn Paul Clancy, Calvin U Cotton, Scott H Donaldson, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2008
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitorsAlita A Miller, Gordon L Bundy, John E Mott, et al.
The New England Journal of Medicine|November 19, 2010
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutationFrank J Accurso, Steven M Rowe, J P Clancy, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Multi-platform framework for mapping somatic retrotransposition in human tissuesSeunghyun Wang, Mingyun Bae, Jinhao Wang, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
Nature Communications|January 8, 2016
Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomesHernan Lorenzi, Asis Khan, Michael S Behnke, et al.
Pageof 99